Medicines shortages and national stockpiling requirements in the EU – Position Paper

15 April 2024

Policy

Beneath the Surface: Unravelling the True Value of Generic Medicines – IQVIA

10 April 2024

Report

Today, generic medicines are an integral part of the healthcare […]

Medicines Procurement Reform: Strenghtening Supply Security through EU Guidance

13 February 2024

Policy

Bolar – Time for an EU action on equal access: No more delays for patients

15 January 2024

Policy

Position Paper – Revision of the Pharmaceutical legislation

8 January 2024

Policy

Note for the rapporteurs/shadow rapporteurs of the EU Pharmaceutical legislation: Impact of extending the duration of regulatory data protection in the new EU pharmaceutical legislation

7 December 2023

Policy

A Fair and Balanced System for Unitary Supplementary Protection Certificates (SPCs) and Centralised Procedure for Granting National SPCs in the European Union

13 November 2023

Policy

Time for an EU action on equal access: No more delays for patients!

10 November 2023

Policy

Review of Nitrosamine Drug Substance Related Impurities (NDSRI) in Pharmaceutical Drugs

30 October 2023

Report

Market review Generic medicines policy 2023 – Policy Statement

29 June 2023

Policy